What are the ESMO guidelines for imaging of non-small cell lung cancer (NSCLC)?

Updated: Aug 27, 2019
  • Author: Sat Sharma, MD, FRCPC; Chief Editor: Eugene C Lin, MD  more...
  • Print


The European Society for Medical Oncology guidelines recommend all patients planned for definitive stage III NSCLC treatment undergo a diagnostic contrast-enhanced CT scan of the chest and upper abdomen followed by a PET or a combined PET-CT with a CT technique with adequately high resolution for initial staging purposes. This will allow detectable extrathoracic, extracranial metastasis to be ruled out, and can assess potential mediastinal lymph node involvement, ideally within 4 weeks before the start of treatment. Single PET-positive distant lesions need pathologic confirmation. [19]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!